Q32 Bio (QTTB) Non Operating Income (2017 - 2026)
Q32 Bio (QTTB) recorded quarterly Non Operating Income of $113000.0 in Q1 2026, down 0.88% quarter-over-quarter from $114000.0 in Q4 2025, and down 90.56% on a YoY basis from $1.2 million in Q1 2025.
Q32 Bio (QTTB) Non Operating Income (2017 - 2026) Analysis & Trends
Q32 Bio's Non Operating Income history runs 10 years deep, the most recent figure standing at $113000.0 for Q1 2026.
- In Q1 2026, Non Operating Income fell 90.56% year-over-year to $113000.0; the TTM figure through Mar 2026 stood at $97000.0 (down 98.12% YoY), while the FY2025 annual figure was $1.2 million, down 94.09% from the prior year.
- Non Operating Income was $113000.0 for Q1 2026 at Q32 Bio, down from $114000.0 in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $131.3 million in Q1 2022 to a low of -$6.2 million in Q3 2023.
- Historically, Non Operating Income has averaged $8.6 million across 5 years, with a median of $578000.0 in 2023.
- The sharpest annual moves came in 2022 and 2023: Non Operating Income jumped 345376.32% in 2022, then slumped 586.05% in 2023.
- A 5-year view of Non Operating Income shows it stood at $1.5 million in 2022, then plunged by 512.16% to -$6.0 million in 2023, then soared by 105.97% to $358000.0 in 2024, then slumped by 68.16% to $114000.0 in 2025, then fell by 0.88% to $113000.0 in 2026.
- The last three Non Operating Income figures came in at $113000.0 (Q1 2026), $114000.0 (Q4 2025), and $188000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 5.75 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 444,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 9.35 Mn |
| 10 | Q32 Bio | 167.59 Mn | 116.84 Mn | - | 113,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 113,000.00 |
| Dec 31, 2025 | 114,000.00 |
| Sep 30, 2025 | 188,000.00 |
| Jun 30, 2025 | -318,000.00 |
| Mar 31, 2025 | 1.20 Mn |
| Dec 31, 2024 | 358,000.00 |
| Sep 30, 2024 | 1.22 Mn |
| Jun 30, 2024 | 2.39 Mn |
| Mar 31, 2024 | 16.05 Mn |
| Dec 31, 2023 | -6.00 Mn |
| Sep 30, 2023 | -6.17 Mn |
| Jun 30, 2023 | 1.47 Mn |
| Mar 31, 2023 | 578,000.00 |
| Dec 31, 2022 | 1.46 Mn |
| Sep 30, 2022 | 1.27 Mn |
| Jun 30, 2022 | 474,000.00 |
| Mar 31, 2022 | 131.28 Mn |
| Dec 31, 2021 | 42,000.00 |
| Sep 30, 2021 | 53,000.00 |
| Jun 30, 2021 | 52,000.00 |